News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
868,095 Results
Type
Article (87830)
Company Profile (824)
Press Release (779427)
Multimedia
Podcasts (188)
Webinars (28)
Section
Business (233192)
Career Advice (4144)
Deals (39851)
Drug Delivery (145)
Drug Development (91384)
Employer Resources (203)
FDA (18371)
Job Trends (17415)
News (397780)
Policy (39955)
Tag
Academia (3006)
Academic (2)
Accelerated approval (31)
Adcomms (36)
Allergies (138)
Alliances (56981)
ALS (175)
Alzheimer's disease (1774)
Antibody-drug conjugate (ADC) (319)
Approvals (18526)
Artificial intelligence (588)
Autoimmune disease (145)
Automation (34)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (198)
Biotechnology (488)
Bladder cancer (155)
Brain cancer (62)
Breast cancer (634)
Cancer (4810)
Cardiovascular disease (421)
Career advice (3566)
Career pathing (40)
CAR-T (296)
CDC (59)
Celiac Disease (1)
Cell therapy (799)
Cervical cancer (37)
Clinical research (76737)
Collaboration (1660)
Company closure (5)
Compensation (1106)
Complete response letters (68)
COVID-19 (2983)
CRISPR (94)
C-suite (781)
Cystic fibrosis (149)
Data (6012)
Decentralized trials (2)
Denatured (69)
Depression (137)
Diabetes (511)
Diagnostics (7188)
Digital health (43)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (286)
Drug pricing (212)
Drug shortages (36)
Duchenne muscular dystrophy (228)
Earnings (99921)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134754)
Executive appointments (1013)
FDA (21360)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (22)
Funding (1465)
Gene editing (205)
Generative AI (60)
Gene therapy (641)
GLP-1 (1101)
Government (5429)
Grass and pollen (8)
Guidances (381)
Healthcare (20941)
HIV (56)
Huntington's disease (46)
IgA nephropathy (82)
Immunology and inflammation (281)
Immuno-oncology (45)
Indications (80)
Infectious disease (3259)
Inflammatory bowel disease (199)
Inflation Reduction Act (17)
Influenza (116)
Intellectual property (229)
Interviews (816)
IPO (17948)
IRA (60)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (653)
Leadership (39)
Legal (10156)
Liver cancer (96)
Longevity (14)
Lung cancer (659)
Lymphoma (368)
Machine learning (40)
Management (66)
Manufacturing (777)
MASH (169)
Medical device (14990)
Medtech (15033)
Mergers & acquisitions (22909)
Metabolic disorders (1333)
Multiple sclerosis (155)
NASH (23)
Neurodegenerative disease (330)
Neuropsychiatric disorders (90)
Neuroscience (3013)
NextGen: Class of 2026 (7704)
Non-profit (5105)
Now hiring (62)
Obesity (642)
Opinion (329)
Ovarian cancer (158)
Pain (194)
Pancreatic cancer (213)
Parkinson's disease (281)
Partnered (37)
Patents (482)
Patient recruitment (438)
Peanut (59)
People (66721)
Pharmaceutical (145)
Pharmacy benefit managers (31)
Phase I (23702)
Phase II (33298)
Phase III (25110)
Pipeline (4273)
Policy (325)
Postmarket research (3554)
Preclinical (10676)
Press Release (72)
Prostate cancer (234)
Psychedelics (53)
Radiopharmaceuticals (295)
Rare diseases (833)
Real estate (7437)
Recruiting (80)
Regulatory (28745)
Reports (65)
Research institute (2719)
Resumes & cover letters (651)
Rett syndrome (25)
RNA editing (16)
RSV (82)
Schizophrenia (152)
Series A (244)
Series B (180)
Service/supplier (30)
Sickle cell disease (102)
Special edition (27)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4329)
State (2)
Stomach cancer (19)
Supply chain (110)
Tariffs (97)
The Weekly (117)
Vaccines (1117)
Venture capital (84)
Weight loss (445)
Women's health (81)
Worklife (21)
Date
Today (198)
Last 7 days (405)
Last 30 days (2003)
Last 365 days (33388)
2026 (405)
2025 (33229)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (333)
Arkansas (14)
Asia (51425)
Australia (9025)
California (11038)
Canada (3220)
China (1101)
Colorado (467)
Connecticut (485)
Delaware (334)
Europe (118128)
Florida (1621)
Georgia (355)
Hawaii (3)
Idaho (68)
Illinois (920)
India (63)
Indiana (527)
Iowa (23)
Japan (403)
Kansas (131)
Kentucky (41)
Louisiana (29)
Maine (81)
Maryland (1415)
Massachusetts (8189)
Michigan (347)
Minnesota (639)
Mississippi (6)
Missouri (136)
Montana (34)
Nebraska (28)
Nevada (119)
New Hampshire (82)
New Jersey (3005)
New Mexico (32)
New York (2946)
North Carolina (1556)
North Dakota (10)
Northern California (5227)
Ohio (337)
Oklahoma (22)
Oregon (53)
Pennsylvania (2226)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (61)
South Dakota (1)
Southern California (4245)
Tennessee (170)
Texas (1747)
United States (40125)
Utah (331)
Vermont (1)
Virginia (277)
Washington D.C. (85)
Washington State (932)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
There are 868,095 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
NextGen
BioSpace’s NextGen Class of 2026 Attracts Big Bucks From Tight Wallets
From biotech veterans to embattled modalities to a new wave of RNAi therapeutics,
BioSpace
’s NextGen Class of 2026 emerged during a tough fundraising environment in 2025. Check out the 15 battle-tested companies that caught our eye.
January 7, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
TempraMed Receives First Commercial Order from Israel Distributor and Completes Initial Shipment Enabling Entry into National Pharmacy Network
Initial shipment delivered to distributor warehouse supports expansion into B2B pharmacy distribution alongside direct-to-consumer activities
January 6, 2026
·
5 min read
Events
Introduction to RNA-Targeting Therapeutics
La Jolla Labs presents a seminar series designed to introduce scientists, clinicians, biotech professionals, and decision-makers to the principles, strategies, and real-world applications of RNA-targeting medicines.
January 6, 2026
Cardiovascular disease
Deep Dive: Huntington’s at a Crossroads
Recent breakthroughs and three decades of progress in treating Huntington’s disease
January 6, 2026
·
2 min read
·
Heather McKenzie
Weight Loss
Arrowhead Enters Obesity Chat by Doubling Tirzepatide’s Weight Loss in Combo Study
Arrowhead heralded the results as proof of concept that inhibiting the Activin E pathway can improve body composition and enhance weight loss as compared to tirzepatide alone, particularly in patients with type 2 diabetes.
January 6, 2026
·
3 min read
·
Annalee Armstrong
Obesity
Lilly Doubles Down With Nimbus, Paying $55M for Preclinical Obesity Drug
Eli Lilly kicked off a pivotal 2026 campaign with a multi-year collaboration with current partner Nimbus Therapeutics worth a potential $1.3 billion for a preclinical obesity therapeutic. The deal follows a 2022 partnership struck by the companies to target the AMPK protein in cardiometabolic diseases.
January 6, 2026
·
2 min read
·
Heather McKenzie
Vaccines
Vaccine Investors Keep Their Heads Down as Trump Cuts Shot Schedule
The US dramatically altered its recommendations for a series of vaccines, which drive billion-dollar earnings for giants like Merck and Pfizer.
January 6, 2026
·
3 min read
·
Dan Samorodnitsky
Press Releases
VB Spine Completes Acquisition of Cestas Manufacturing Facility from Stryker
January 6, 2026
·
4 min read
Press Releases
STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
January 6, 2026
·
2 min read
Press Releases
BioMendics Brings New Hope for Epidermolysis Bullosa Simplex Patients as TAMES‑02 Trial Advances and JPM Week Approaches
January 6, 2026
·
4 min read
1 of 86,810
Next
